Prophylaxis for Patients at Risk of COVID-19 Infection: Results from the Intranasal Niclosamide Randomised, Double Blinded, Placebo Controlled Arm of the PROTECT-V Platform Trial
Humphrey et al., Elsevier BV, doi:10.2139/ssrn.4519538
https://c19early.org/humphrey.html